Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.

Name: Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.
Author: Morón-López, Sara

Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals. — المؤلف: Morón-López, Sara — Clinical infectious diseas

المؤلف: Morón-López, Sara
النشر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20200914
الوصف: 1320-1328 p.
الموضوعات: Anti-Retroviral Agents؛ Biopsy؛ Female؛ HIV؛ HIV Infections؛ HIV Integrase Inhibitors؛ HIV Protease Inhibitors؛ Heterocyclic Compounds, 3-Ring